Features | Partner Sites | Information | LinkXpress
Sign In
JIB
BioConferenceLive
GLOBETECH PUBLISHING

Human Stem Cell Graft Stimulates Neuron Regeneration in Rats with Spinal Injury

By BiotechDaily International staff writers
Posted on 06 Jun 2013
Image: A three-dimensional, reconstructed magnetic resonance image (upper) shows a cavity caused by a spinal injury nearly filled with grafted neural stem cells, colored green. The lower image depicts neuronal outgrowth from transplanted human neurons (green) and development of putative contacts (yellow dots) with host neurons (blue) (Photo courtesy of the University of California, San Diego School of Medicine).
Image: A three-dimensional, reconstructed magnetic resonance image (upper) shows a cavity caused by a spinal injury nearly filled with grafted neural stem cells, colored green. The lower image depicts neuronal outgrowth from transplanted human neurons (green) and development of putative contacts (yellow dots) with host neurons (blue) (Photo courtesy of the University of California, San Diego School of Medicine).
Image: Senior author Dr. Martin Marsala (Photo courtesy of the University of California, San Diego School of Medicine).
Image: Senior author Dr. Martin Marsala (Photo courtesy of the University of California, San Diego School of Medicine).
Human neural stem cells injected into rats with acute spinal cord injury generated connections between the injected stem cells and surviving host neurons, which stimulated host neuron regeneration and partially replaced the neurons destroyed by the injury.

Investigators at the University of California, San Diego School of Medicine (USA) worked with a model system comprising three-month-old female Sprague-Dawley rats with induced spinal compression injury. Three days postinjury, the animals were randomized and some received intraspinal injections of either human fetal spinal cord-derived neural stem cells (HSSC) or media-only, or did not receive an injection. All animals were immunosuppressed from the day of cell grafting and survived for eight weeks.

Results published in the May 28, 2013, online edition of the journal Stem Cell Research & Therapy revealed that the intraspinal grafting of HSSC in the injured animals led to a progressive and significant improvement in lower extremity paw placement, amelioration of spasticity, and normalization in thermal and tactile pain/escape thresholds at eight weeks post-grafting. Magnetic resonance imaging volume reconstruction and immunofluorescence analysis of grafted cell survival showed near complete injury-cavity-filling by grafted cells and development of putative synapses between grafted and host neurons.


comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Lab Technologies

view channel

Precise Ion Irradiation Dosing Method Developed for Cancer Therapy

Scientists are employing nuclear physics principles to provide more effective approaches to radiotherapy treatment for cancer patients. Radiation therapy using heavy ions is best suitable for cancer patients with tumors that are difficult to access, such as in the brain. These particles scarcely damage the penetrated... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.